PDL BioPharma Competitors and Similar CompaniesClear all
PDL BioPharma's competitors and similar companies include Immunomedics, TSH Biopharm, Ascentage Pharma and Achilles Therapeutics.
 PDL BioPharma PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities. |  Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. |  Ascentage Pharma Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies. |  Achilles Therapeutics Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer. | ||
Founding Date | Founding Date 1986 | Founding Date 1982 | Founding Date 2010 | Founding Date 2017 | Founding Date 2016 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Incline Village, US HQ | Locations Morris Plains, US HQ | Locations TW HQ | Locations Suzhou, CN HQ Guangzhou Shi, CN Suzhou Shi, CN Taizhou, CN Rockville, US | Locations London, GB HQ Stevenage, GB |
Employees | Employees 10521% increase | Employees 8914% decrease | Employees 76 | Employees 567 | Employees 695% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) $54.8m (FY, 2019) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) NT$1.3b (FY, 2025) | Revenue (est.) ¥574.1m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $53.6m (FY, 2019) | Cost of goods N/A | Cost of goods NT$629m (FY, 2025) | Cost of goods ¥48.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $1.1m (FY, 2019) | Gross profit $295k (FY, 2019) | Gross profit NT$709.7m (FY, 2025) | Gross profit ¥546.6m (FY, 2025) | Gross profit N/A |
Net income | Net income ($70.7m) (FY, 2019) | Net income ($357.3m) (FY, 2019) | Net income NT$187.8m (FY, 2025) | Net income (¥1.2b) (FY, 2025) | Net income ($69.7m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 30m | Total funding raised N/A | Total funding raised $ 237.5m | Total funding raised $ 138.1m |
For sources of this data, please see the company profile
View Company Profiles
Immunomedics
HQ
Morris Plains, US
Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer.
View company
TSH Biopharm
HQ
TW
Employees
76
TSH Biopharm (東生華製藥股份有限公司) is a pharmaceutical company focused on chronic diseases.
View companyAscentage Pharma
HQ
Suzhou, CN
Employees
567
Ascentage Pharma Group International (亚盛闘棄集團) is a biopharmaceutical company that is engaged in discovering, developing, and commercializing therapies.
View companyAchilles Therapeutics
HQ
London, GB
Employees
69↓ 5% decrease
Achilles Therapeutics is a developer of immunotherapies intended to offer therapies to treat cancer.
View company